NCT04373057 - Prebiotic Galacto-oligosaccharide and Acute GVHD | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

February 1, 2028

Conditions

Acute GVHD

Interventions

DIETARY_SUPPLEMENT

Galacto-oligosaccharide

GOS will be administered at determined dose levels per protocol once daily from about 30 days before transplant to about 4 weeks after transplant.

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin will be administered at comparable dose level as GOS (in Phase II) once daily from about 30 days before transplant to about 4 weeks after transplant.

Trial Locations (2)

27710

ACTIVE_NOT_RECRUITING

Duke, Durham

66160

RECRUITING

Kansas University Medical Center, Kansas City